LLS News Network

News and Information from The Leukemia & Lymphoma Society

LLS and ASH Team Up to Connect Cancer Patients to Clinical Trials...

Collaboration will provide critical clinical trial navigation services and support to patients and families (Rye Brook, NY – December 6, 2019) The Leukemia & Lymphoma Society (LLS) and the American Society of Hematology (ASH) announced today a collaboration to expand access to LLS’s unique free service providing clinical trials navigation and support to blood cancer patients and their families. With only a...

Walgreens, Susan G. Komen and LLS Collaborate to Support Research...

DEERFIELD, Ill., DALLAS and RYE BROOK, N.Y., Oct. 22, 2019 – Walgreens announced today a new collaboration with Susan G. Komen and The Leukemia & Lymphoma Society to enable research in tough-to-treat cancers and increase access to care with a pledge to contribute more than $25 million to the organizations, collectively, over the next five years. Through a combination of corporate donations and in-store fundra...

Nearly 60% of Blood Cancer Patients Covered By Medicare Delay or ...

View full multimedia release here.  Rye Brook, N.Y. (October 21, 2019) – Survival of older patients with blood cancers continues to improve as more effective, less toxic therapies are introduced. However, these lifesaving treatments often are expensive and many cancer patients face financial burdens caused by ever-increasing healthcare costs. In fact, according to a new study  released toda...

WWE® AND LLS JOIN FORCES TO HELP CANCER PATIENTS AND FAMILIES

Stamford, Conn. and Rye Brook, N.Y. (October 03, 2019) – WWE and WWE Superstar Roman Reigns are teaming up with The Leukemia & Lymphoma Society (LLS) in the fight against cancer. For Reigns, the cause is personal – he is in remission for the second time from chronic myeloid leukemia (CML). The new partnership with LLS, the world’s largest nonprofit fighting blood cancers, will propel the organization’...

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: